SQ Innovation
Subcutaneous drug-delivery devices (Lasix ONYU)
Privately held: no public share price · Switzerland
Assets
(1 total)
1Total Assets
1Approved
0Phase 3 / Filed
0Phase 1–2 / Early
1Diseases
| Target & Modality | |||
|---|---|---|---|
Furosemide (subcutaneous, SQ Innovation)(Lasix ONYU) | Approved | NKCC2Small molecule | Heart Failure |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
No financial reports recorded.